EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY 4.0

Increased risk of kidney failure in patients with genetic kidney disorders

Mark D Elliott, Natalie Vena, Maddalena Marasa, Enrico Cocchi, Shiraz Bheda, Kelsie Bogyo, Ning Shang, Francesca Zanoni, Miguel Verbitsky, Chen Wang, Victoria Kolupaeva, Gina Jin und 21 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci178573 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Mark D Elliott und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA. Hauptthemen laut MEDLINE: Apolipoprotein L1, Renal Insufficiency, Glomerular Filtration Rate. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHGRI NIH HHS, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND It is unknown whether the risk of kidney disease progression and failure differs between patients with and without genetic kidney disorders. METHODS Three cohorts were evaluated: the prospective Cure Glomerulonephropathy Network (CureGN) and 2 retrospective cohorts from Columbia University, including 5,727 adults and children with kidney disease from any etiology who underwent whole-genome or exome sequencing. The effects of monogenic kidney disorders and APOL1 kidney-risk genotypes on the risk of kidney failure, estimated glomerular filtration rate (eGFR) decline, and disease remission rates were evaluated along with diagnostic yields and the impact of American College of Medical Genetics secondary findings (ACMG SFs). RESULTS Monogenic kidney disorders were identified in 371 patients (6.5%), high-risk APOL1 genotypes in 318 (5.5%), and ACMG SFs in 100 (5.2%). Family history of kidney disease was the strongest predictor of monogenic disorders. After adjustment for traditional risk factors, monogenic kidney disorders were associated with an increased risk of kidney failure (hazard ratio [HR] = 1.72), higher rate of eGFR decline (–3.06 vs. 0.25 mL/min/1.73 m 2 /year), and lower risk of complete remission (odds ratio Not achieving CR = 5.25). High-risk APOL1 genotypes were associated with an increased risk of kidney failure (HR = 1.67) and faster eGFR decline (–2.28 vs. 0.25 mL/min/1.73 m 2 ), replicating prior findings. ACMG SFs were not associated with personal or family history of associated diseases, but were predicted to impact care in 70% of cases. CONCLUSIONS Monogenic kidney disorders were associated with an increased risk of kidney failure, faster eGFR decline, and lower rates of complete remission, suggesting opportunities for early identification and intervention based on molecular diagnosis. TRIAL REGISTRATION NA. FUNDING National Institute of Diabetes and Digestive and Kidney Diseases grants U24DK100845 (formerly UM1DK100845), U01DK100846 (formerly UM1DK100846), U01DK100876 (formerly UM1DK100876), U01DK100866 (formerly UM1DK100866), U01DK100867 (formerly UM1DK100867), U24DK100845, DK081943, RC2DK116690, 2U01DK100876, 1R01DK136765, 5R01DK082753, and RC2-DK122397; NephCure Kidney International; Department of Defense Research Awards PR201425, W81XWH-16-1-0451, and W81XWH-22-1-0966; National Center for Advancing Translational Sciences grant UL1TR001873; National Library of Medicine grant R01LM013061; National Human Genome Research Institute grant 2U01HG008680.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein L1Renal InsufficiencyGlomerular Filtration RateHumansMaleFemaleAdultMiddle AgedRisk FactorsChildRetrospective StudiesAdolescentProspective StudiesKidney Diseases

Stichwörter der Autor:innen

Chronic kidney diseaseGenetic diseasesGeneticsMolecular diagnosisNephrology

Substanzen

Apolipoprotein L1APOL1 protein, human

Autor:innen und Institutionen

  • Department of Medicine, Division of Nephrology, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA.
  • University of British Columbia, Vancouver, British Columbia, Canada.
  • Neonatal and Pediatric Intensive Care Unit, Bufalini Hospital, AUSL Romagna, Ravenna, Italy.
  • University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics, Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Laboratory Medicine and Pathology, Cedars Sinai Medical Center, Los Angeles, California, USA.

Förderung

  • NIDDK NIH HHS
  • NHGRI NIH HHS
  • NIDDK
  • NLM
  • NHGRI
  • NCATS

Zitieren

APA

Elliott, M. D., Vena, N., Marasa, M., Cocchi, E., Bheda, S., Bogyo, K., Shang, N., Zanoni, F., Verbitsky, M., Wang, C., Kolupaeva, V., Jin, G., Sofer, M., Gras Pena, R., Canetta, P. A., Bomback, A. S., Guay-Woodford, L. M., Hou, J., Gillespie, B. W., …, & CureGN Consortium (2024). Increased risk of kidney failure in patients with genetic kidney disorders. Journal of Clinical Investigation. https://doi.org/10.1172/jci178573

Vancouver

Elliott MD, Vena N, Marasa M, Cocchi E, Bheda S, Bogyo K, et al. Increased risk of kidney failure in patients with genetic kidney disorders. Journal of Clinical Investigation. 2024. doi:10.1172/jci178573

BibTeX
@article{Elliott2024,
  author = {Elliott, Mark D and Vena, Natalie and Marasa, Maddalena and Cocchi, Enrico and Bheda, Shiraz and Bogyo, Kelsie and Shang, Ning and Zanoni, Francesca and Verbitsky, Miguel and Wang, Chen and Kolupaeva, Victoria and Jin, Gina and Sofer, Maayan and Gras Pena, Rafael and Canetta, Pietro A and Bomback, Andrew S and Guay-Woodford, Lisa M and Hou, Jean and Gillespie, Brenda W and Robinson, Bruce M and Klein, Jon B and Rheault, Michelle N and Smoyer, William E and Greenbaum, Larry A and Holzman, Larry B and Falk, Ronald J and Parsa, Afshin and Sanna-Cherchi, Simone and Mariani, Laura H and Kretzler, Matthias and Kiryluk, Krzysztof and Gharavi, Ali G and CureGN Consortium, CureGN Consortium},
  title = {Increased risk of kidney failure in patients with genetic kidney disorders},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci178573}
}
Kostenlos starten →